RecruitingNot ApplicableNCT06286644

Hop Compounds on the Immune System (VH)

Effect of Iso-alpha Acids and Xanthohumol on the Human Immune System


Sponsor

University of Vienna

Enrollment

14 participants

Start Date

May 30, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the present study is to determine the effect of Iso-alpha-Acids and Xanthohumol from hops on the immune response of healthy participants over a timeframe of 6 hours.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria2

  • healthy
  • BMI: >18,5 kg/m² or <30 kg/m²

Exclusion Criteria6

  • food intolerances
  • food allergies
  • chronic inflammatory diseases
  • metabolic diseases
  • viral or bacterial infections within the last 3 weeks of inclusion
  • intake of immunosuppressive medication

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTXanthohumol

Participants receive a study drink supplemented with Xanthohumol (0 mg = Placebo, 0,125 mg, 0,375 mg or 0,75 mg soluble Xanthohumol)

DIETARY_SUPPLEMENTIso-alpha-Acids

Participants receive a study drink supplemented with Iso-alpha-Acids (0 mg = Placebo, 15 mg, 45 mg or 90 mg Iso-alpha-Acids)

DIETARY_SUPPLEMENTXanthohumol + Iso-alpha-Acids

Participants receive a study drink supplemented with Xanthohumol + Iso-alpha-Acids (0 mg = Placebo, 0,125 mg + 15 mg , 0,375 mg + 45 mg or 0,75 mg + 90 mg soluble Xanthohumol + Iso-alpha-Acids)


Locations(1)

University of Vienna

Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06286644


Related Trials